Site icon Fact.MR Blog

Non-Invasive Aesthetic Treatment Market Is Expected To Grow With The Compound Annual Growth Rate CAGR Of 16.5% By 2032

The revenue from injectables in 2021 was US$ 33.8 Bn and is expected to grow above 5X during the forecast period. The demand for injectables primarily comes from North America, Europe and APAC region, and these three regions collectively generated more than 85% revenue of injectables.

The non-Invasive aesthetic market revenues were estimated at US$ 53.3 Bn in 2021 and is anticipated to grow at a CAGR of 16.5% from 2022-2032, according to a recently published Fact.MR report. By the end of 2032, the market is expected to reach US$ 281.2 Bn.

The outbreak of Covid19 has impacted all the regions of the world as it affected medical tourism and the flow of medical services. As almost all the countries faced lockdown during the period, also patient appointments for non-invasive aesthetic treatments were temporarily halted.

Request Sample

Market Segments Covered in Non-Invasive Aesthetic Treatment Market Analysis

Competitive Analysis

Key players in the non-invasive aesthetic treatment market are focusing on growth strategies such as Improvement of existing technology, geographic expansion, product launch and product approval, to gain higher market share. Various development strategies help raise consumer awareness of new processes and products, such as product launches and collaborations.

The major players in the global non-invasive aesthetic treatment market are Allergan, Inc., Hologic Inc., Alma Lasers, Syneron Candela, Galderma S.A., Johnson & Johnson, Lumenis, Solta Medical, Cutera Inc., Revance Therapeutics Inc. and MerzPharma

Exit mobile version